Medical Care
Global Antibody Conjugation Service Market Research Report 2024
- Jan 20, 24
- ID: 32865
- Pages: 101
- Figures: 221
- Views: 34
Antibody conjugation service refers to a process in which antibodies are chemically modified by attaching various tags or ligands to their specific binding sites, enabling them to bind to various targets such as cells, proteins, or other molecules. This process is typically performed by specialized laboratories or service providers using various conjugation techniques such as click conjugation, biotin-avidin binding, etc. The goal of this service is to improve the specificity and affinity of antibodies for their targets, as well as to enhance their functional capabilities.
The global Antibody Conjugation Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation Service.
Report Scope
The Antibody Conjugation Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Segment by Type
Chemical Compound
Fluorescent Group
Isotope
Protein
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antibody Conjugation Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation Service.
Report Scope
The Antibody Conjugation Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Segment by Type
Chemical Compound
Fluorescent Group
Isotope
Protein
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical Compound
1.2.3 Fluorescent Group
1.2.4 Isotope
1.2.5 Protein
1.3 Market by Application
1.3.1 Global Antibody Conjugation Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation Service Market Perspective (2019-2030)
2.2 Antibody Conjugation Service Growth Trends by Region
2.2.1 Global Antibody Conjugation Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Conjugation Service Historic Market Size by Region (2019-2024)
2.2.3 Antibody Conjugation Service Forecasted Market Size by Region (2025-2030)
2.3 Antibody Conjugation Service Market Dynamics
2.3.1 Antibody Conjugation Service Industry Trends
2.3.2 Antibody Conjugation Service Market Drivers
2.3.3 Antibody Conjugation Service Market Challenges
2.3.4 Antibody Conjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation Service Players by Revenue
3.1.1 Global Top Antibody Conjugation Service Players by Revenue (2019-2024)
3.1.2 Global Antibody Conjugation Service Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Conjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Conjugation Service Revenue
3.4 Global Antibody Conjugation Service Market Concentration Ratio
3.4.1 Global Antibody Conjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation Service Revenue in 2023
3.5 Antibody Conjugation Service Key Players Head office and Area Served
3.6 Key Players Antibody Conjugation Service Product Solution and Service
3.7 Date of Enter into Antibody Conjugation Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation Service Breakdown Data by Type
4.1 Global Antibody Conjugation Service Historic Market Size by Type (2019-2024)
4.2 Global Antibody Conjugation Service Forecasted Market Size by Type (2025-2030)
5 Antibody Conjugation Service Breakdown Data by Application
5.1 Global Antibody Conjugation Service Historic Market Size by Application (2019-2024)
5.2 Global Antibody Conjugation Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Conjugation Service Market Size (2019-2030)
6.2 North America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Conjugation Service Market Size by Country (2019-2024)
6.4 North America Antibody Conjugation Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation Service Market Size (2019-2030)
7.2 Europe Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Conjugation Service Market Size by Country (2019-2024)
7.4 Europe Antibody Conjugation Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation Service Market Size (2019-2030)
8.2 Asia-Pacific Antibody Conjugation Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Conjugation Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Conjugation Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation Service Market Size (2019-2030)
9.2 Latin America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Conjugation Service Market Size by Country (2019-2024)
9.4 Latin America Antibody Conjugation Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation Service Market Size (2019-2030)
10.2 Middle East & Africa Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Conjugation Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Conjugation Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Detail
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation Service Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation Service Business (2019-2024)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation Service Introduction
11.3.4 Abcam Revenue in Antibody Conjugation Service Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation Service Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Detail
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation Service Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation Service Business (2019-2024)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Detail
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation Service Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation Service Business (2019-2024)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Detail
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation Service Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation Service Business (2019-2024)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation Service Introduction
11.8.4 GenScript Revenue in Antibody Conjugation Service Business (2019-2024)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Detail
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation Service Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Detail
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation Service Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation Service Business (2019-2024)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Detail
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation Service Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation Service Business (2019-2024)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Detail
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation Service Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation Service Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Detail
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation Service Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation Service Business (2019-2024)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Detail
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation Service Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Detail
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation Service Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Detail
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation Service Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation Service Business (2019-2024)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Detail
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation Service Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation Service Business (2019-2024)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation Service Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Detail
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation Service Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation Service Business (2019-2024)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Detail
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation Service Introduction
11.20.4 Merck Revenue in Antibody Conjugation Service Business (2019-2024)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Detail
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation Service Introduction
11.21.4 Lonza Revenue in Antibody Conjugation Service Business (2019-2024)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Detail
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation Service Introduction
11.22.4 Charles River Revenue in Antibody Conjugation Service Business (2019-2024)
11.22.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical Compound
1.2.3 Fluorescent Group
1.2.4 Isotope
1.2.5 Protein
1.3 Market by Application
1.3.1 Global Antibody Conjugation Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation Service Market Perspective (2019-2030)
2.2 Antibody Conjugation Service Growth Trends by Region
2.2.1 Global Antibody Conjugation Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Conjugation Service Historic Market Size by Region (2019-2024)
2.2.3 Antibody Conjugation Service Forecasted Market Size by Region (2025-2030)
2.3 Antibody Conjugation Service Market Dynamics
2.3.1 Antibody Conjugation Service Industry Trends
2.3.2 Antibody Conjugation Service Market Drivers
2.3.3 Antibody Conjugation Service Market Challenges
2.3.4 Antibody Conjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation Service Players by Revenue
3.1.1 Global Top Antibody Conjugation Service Players by Revenue (2019-2024)
3.1.2 Global Antibody Conjugation Service Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Conjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Conjugation Service Revenue
3.4 Global Antibody Conjugation Service Market Concentration Ratio
3.4.1 Global Antibody Conjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation Service Revenue in 2023
3.5 Antibody Conjugation Service Key Players Head office and Area Served
3.6 Key Players Antibody Conjugation Service Product Solution and Service
3.7 Date of Enter into Antibody Conjugation Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation Service Breakdown Data by Type
4.1 Global Antibody Conjugation Service Historic Market Size by Type (2019-2024)
4.2 Global Antibody Conjugation Service Forecasted Market Size by Type (2025-2030)
5 Antibody Conjugation Service Breakdown Data by Application
5.1 Global Antibody Conjugation Service Historic Market Size by Application (2019-2024)
5.2 Global Antibody Conjugation Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Conjugation Service Market Size (2019-2030)
6.2 North America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Conjugation Service Market Size by Country (2019-2024)
6.4 North America Antibody Conjugation Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation Service Market Size (2019-2030)
7.2 Europe Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Conjugation Service Market Size by Country (2019-2024)
7.4 Europe Antibody Conjugation Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation Service Market Size (2019-2030)
8.2 Asia-Pacific Antibody Conjugation Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Conjugation Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Conjugation Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation Service Market Size (2019-2030)
9.2 Latin America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Conjugation Service Market Size by Country (2019-2024)
9.4 Latin America Antibody Conjugation Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation Service Market Size (2019-2030)
10.2 Middle East & Africa Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Conjugation Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Conjugation Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Detail
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation Service Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation Service Business (2019-2024)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation Service Introduction
11.3.4 Abcam Revenue in Antibody Conjugation Service Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation Service Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Detail
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation Service Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation Service Business (2019-2024)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Detail
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation Service Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation Service Business (2019-2024)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Detail
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation Service Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation Service Business (2019-2024)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation Service Introduction
11.8.4 GenScript Revenue in Antibody Conjugation Service Business (2019-2024)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Detail
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation Service Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Detail
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation Service Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation Service Business (2019-2024)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Detail
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation Service Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation Service Business (2019-2024)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Detail
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation Service Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation Service Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Detail
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation Service Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation Service Business (2019-2024)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Detail
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation Service Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Detail
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation Service Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Detail
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation Service Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation Service Business (2019-2024)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Detail
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation Service Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation Service Business (2019-2024)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation Service Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Detail
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation Service Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation Service Business (2019-2024)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Detail
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation Service Introduction
11.20.4 Merck Revenue in Antibody Conjugation Service Business (2019-2024)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Detail
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation Service Introduction
11.21.4 Lonza Revenue in Antibody Conjugation Service Business (2019-2024)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Detail
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation Service Introduction
11.22.4 Charles River Revenue in Antibody Conjugation Service Business (2019-2024)
11.22.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antibody Conjugation Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemical Compound
Table 3. Key Players of Fluorescent Group
Table 4. Key Players of Isotope
Table 5. Key Players of Protein
Table 6. Global Antibody Conjugation Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antibody Conjugation Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Antibody Conjugation Service Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Antibody Conjugation Service Market Share by Region (2019-2024)
Table 10. Global Antibody Conjugation Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Antibody Conjugation Service Market Share by Region (2025-2030)
Table 12. Antibody Conjugation Service Market Trends
Table 13. Antibody Conjugation Service Market Drivers
Table 14. Antibody Conjugation Service Market Challenges
Table 15. Antibody Conjugation Service Market Restraints
Table 16. Global Antibody Conjugation Service Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Antibody Conjugation Service Market Share by Players (2019-2024)
Table 18. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2023)
Table 19. Ranking of Global Top Antibody Conjugation Service Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Antibody Conjugation Service Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Conjugation Service Product Solution and Service
Table 23. Date of Enter into Antibody Conjugation Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody Conjugation Service Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Antibody Conjugation Service Revenue Market Share by Type (2019-2024)
Table 27. Global Antibody Conjugation Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Antibody Conjugation Service Revenue Market Share by Type (2025-2030)
Table 29. Global Antibody Conjugation Service Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Antibody Conjugation Service Revenue Market Share by Application (2019-2024)
Table 31. Global Antibody Conjugation Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Antibody Conjugation Service Revenue Market Share by Application (2025-2030)
Table 33. North America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Antibody Conjugation Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Antibody Conjugation Service Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Antibody Conjugation Service Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 48. ProSci, Inc Company Detail
Table 49. ProSci, Inc Business Overview
Table 50. ProSci, Inc Antibody Conjugation Service Product
Table 51. ProSci, Inc Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 52. ProSci, Inc Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Antibody Conjugation Service Product
Table 56. Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Abcam Company Detail
Table 59. Abcam Business Overview
Table 60. Abcam Antibody Conjugation Service Product
Table 61. Abcam Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 62. Abcam Recent Development
Table 63. Cell Signaling Technology Company Detail
Table 64. Cell Signaling Technology Business Overview
Table 65. Cell Signaling Technology Antibody Conjugation Service Product
Table 66. Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 67. Cell Signaling Technology Recent Development
Table 68. Bio X Cell Company Detail
Table 69. Bio X Cell Business Overview
Table 70. Bio X Cell Antibody Conjugation Service Product
Table 71. Bio X Cell Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 72. Bio X Cell Recent Development
Table 73. SouthernBiotech Company Detail
Table 74. SouthernBiotech Business Overview
Table 75. SouthernBiotech Antibody Conjugation Service Product
Table 76. SouthernBiotech Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 77. SouthernBiotech Recent Development
Table 78. Novus Biologicals Company Detail
Table 79. Novus Biologicals Business Overview
Table 80. Novus Biologicals Antibody Conjugation Service Product
Table 81. Novus Biologicals Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 82. Novus Biologicals Recent Development
Table 83. GenScript Company Detail
Table 84. GenScript Business Overview
Table 85. GenScript Antibody Conjugation Service Product
Table 86. GenScript Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 87. GenScript Recent Development
Table 88. Leinco Technologies Company Detail
Table 89. Leinco Technologies Business Overview
Table 90. Leinco Technologies Antibody Conjugation Service Product
Table 91. Leinco Technologies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 92. Leinco Technologies Recent Development
Table 93. Standard BioTools Company Detail
Table 94. Standard BioTools Business Overview
Table 95. Standard BioTools Antibody Conjugation Service Product
Table 96. Standard BioTools Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 97. Standard BioTools Recent Development
Table 98. AlphaThera Company Detail
Table 99. AlphaThera Business Overview
Table 100. AlphaThera Antibody Conjugation Service Product
Table 101. AlphaThera Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 102. AlphaThera Recent Development
Table 103. Creative Biolabs Company Detail
Table 104. Creative Biolabs Business Overview
Table 105. Creative Biolabs Antibody Conjugation Service Product
Table 106. Creative Biolabs Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 107. Creative Biolabs Recent Development
Table 108. Antibodies Company Detail
Table 109. Antibodies Business Overview
Table 110. Antibodies Antibody Conjugation Service Product
Table 111. Antibodies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 112. Antibodies Recent Development
Table 113. Boster Biological Technology Company Detail
Table 114. Boster Biological Technology Business Overview
Table 115. Boster Biological Technology Antibody Conjugation Service Product
Table 116. Boster Biological Technology Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 117. Boster Biological Technology Recent Development
Table 118. Cygnus Technologies Company Detail
Table 119. Cygnus Technologies Business Overview
Table 120. Cygnus Technologies Antibody Conjugation Service Product
Table 121. Cygnus Technologies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 122. Cygnus Technologies Recent Development
Table 123. Cayman Chemical Company Detail
Table 124. Cayman Chemical Business Overview
Table 125. Cayman Chemical Antibody Conjugation Service Product
Table 126. Cayman Chemical Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 127. Cayman Chemical Recent Development
Table 128. GeneTex Company Detail
Table 129. GeneTex Business Overview
Table 130. GeneTex Antibody Conjugation Service Product
Table 131. GeneTex Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 132. GeneTex Recent Development
Table 133. ProteoGenix Company Detail
Table 134. ProteoGenix Business Overview
Table 135. ProteoGenix Antibody Conjugation Service Product
Table 136. ProteoGenix Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 137. ProteoGenix Recent Development
Table 138. Levena Biopharma Company Detail
Table 139. Levena Biopharma Business Overview
Table 140. Levena Biopharma Antibody Conjugation Service Product
Table 141. Levena Biopharma Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 142. Levena Biopharma Recent Development
Table 143. Merck Company Detail
Table 144. Merck Business Overview
Table 145. Merck Antibody Conjugation Service Product
Table 146. Merck Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 147. Merck Recent Development
Table 148. Lonza Company Detail
Table 149. Lonza Business Overview
Table 150. Lonza Antibody Conjugation Service Product
Table 151. Lonza Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 152. Lonza Recent Development
Table 153. Charles River Company Detail
Table 154. Charles River Business Overview
Table 155. Charles River Antibody Conjugation Service Product
Table 156. Charles River Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 157. Charles River Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Conjugation Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antibody Conjugation Service Market Share by Type: 2023 VS 2030
Figure 3. Chemical Compound Features
Figure 4. Fluorescent Group Features
Figure 5. Isotope Features
Figure 6. Protein Features
Figure 7. Global Antibody Conjugation Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Antibody Conjugation Service Market Share by Application: 2023 VS 2030
Figure 9. Biotechnology Case Studies
Figure 10. Medical Case Studies
Figure 11. University Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Conjugation Service Report Years Considered
Figure 14. Global Antibody Conjugation Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Antibody Conjugation Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Antibody Conjugation Service Market Share by Region: 2023 VS 2030
Figure 17. Global Antibody Conjugation Service Market Share by Players in 2023
Figure 18. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Conjugation Service Revenue in 2023
Figure 20. North America Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 22. United States Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 26. Germany Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Antibody Conjugation Service Market Share by Region (2019-2030)
Figure 34. China Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 42. Mexico Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 46. Turkey Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. ProSci, Inc Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 50. Abcam Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 51. Cell Signaling Technology Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 52. Bio X Cell Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 53. SouthernBiotech Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 54. Novus Biologicals Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 55. GenScript Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 56. Leinco Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 57. Standard BioTools Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 58. AlphaThera Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 59. Creative Biolabs Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 60. Antibodies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 61. Boster Biological Technology Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 62. Cygnus Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 63. Cayman Chemical Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 64. GeneTex Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 65. ProteoGenix Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 66. Levena Biopharma Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 67. Merck Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 68. Lonza Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 69. Charles River Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Antibody Conjugation Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemical Compound
Table 3. Key Players of Fluorescent Group
Table 4. Key Players of Isotope
Table 5. Key Players of Protein
Table 6. Global Antibody Conjugation Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antibody Conjugation Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Antibody Conjugation Service Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Antibody Conjugation Service Market Share by Region (2019-2024)
Table 10. Global Antibody Conjugation Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Antibody Conjugation Service Market Share by Region (2025-2030)
Table 12. Antibody Conjugation Service Market Trends
Table 13. Antibody Conjugation Service Market Drivers
Table 14. Antibody Conjugation Service Market Challenges
Table 15. Antibody Conjugation Service Market Restraints
Table 16. Global Antibody Conjugation Service Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Antibody Conjugation Service Market Share by Players (2019-2024)
Table 18. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2023)
Table 19. Ranking of Global Top Antibody Conjugation Service Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Antibody Conjugation Service Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibody Conjugation Service Product Solution and Service
Table 23. Date of Enter into Antibody Conjugation Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibody Conjugation Service Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Antibody Conjugation Service Revenue Market Share by Type (2019-2024)
Table 27. Global Antibody Conjugation Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Antibody Conjugation Service Revenue Market Share by Type (2025-2030)
Table 29. Global Antibody Conjugation Service Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Antibody Conjugation Service Revenue Market Share by Application (2019-2024)
Table 31. Global Antibody Conjugation Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Antibody Conjugation Service Revenue Market Share by Application (2025-2030)
Table 33. North America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Antibody Conjugation Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Antibody Conjugation Service Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Antibody Conjugation Service Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antibody Conjugation Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Antibody Conjugation Service Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Antibody Conjugation Service Market Size by Country (2025-2030) & (US$ Million)
Table 48. ProSci, Inc Company Detail
Table 49. ProSci, Inc Business Overview
Table 50. ProSci, Inc Antibody Conjugation Service Product
Table 51. ProSci, Inc Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 52. ProSci, Inc Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Antibody Conjugation Service Product
Table 56. Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Abcam Company Detail
Table 59. Abcam Business Overview
Table 60. Abcam Antibody Conjugation Service Product
Table 61. Abcam Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 62. Abcam Recent Development
Table 63. Cell Signaling Technology Company Detail
Table 64. Cell Signaling Technology Business Overview
Table 65. Cell Signaling Technology Antibody Conjugation Service Product
Table 66. Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 67. Cell Signaling Technology Recent Development
Table 68. Bio X Cell Company Detail
Table 69. Bio X Cell Business Overview
Table 70. Bio X Cell Antibody Conjugation Service Product
Table 71. Bio X Cell Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 72. Bio X Cell Recent Development
Table 73. SouthernBiotech Company Detail
Table 74. SouthernBiotech Business Overview
Table 75. SouthernBiotech Antibody Conjugation Service Product
Table 76. SouthernBiotech Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 77. SouthernBiotech Recent Development
Table 78. Novus Biologicals Company Detail
Table 79. Novus Biologicals Business Overview
Table 80. Novus Biologicals Antibody Conjugation Service Product
Table 81. Novus Biologicals Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 82. Novus Biologicals Recent Development
Table 83. GenScript Company Detail
Table 84. GenScript Business Overview
Table 85. GenScript Antibody Conjugation Service Product
Table 86. GenScript Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 87. GenScript Recent Development
Table 88. Leinco Technologies Company Detail
Table 89. Leinco Technologies Business Overview
Table 90. Leinco Technologies Antibody Conjugation Service Product
Table 91. Leinco Technologies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 92. Leinco Technologies Recent Development
Table 93. Standard BioTools Company Detail
Table 94. Standard BioTools Business Overview
Table 95. Standard BioTools Antibody Conjugation Service Product
Table 96. Standard BioTools Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 97. Standard BioTools Recent Development
Table 98. AlphaThera Company Detail
Table 99. AlphaThera Business Overview
Table 100. AlphaThera Antibody Conjugation Service Product
Table 101. AlphaThera Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 102. AlphaThera Recent Development
Table 103. Creative Biolabs Company Detail
Table 104. Creative Biolabs Business Overview
Table 105. Creative Biolabs Antibody Conjugation Service Product
Table 106. Creative Biolabs Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 107. Creative Biolabs Recent Development
Table 108. Antibodies Company Detail
Table 109. Antibodies Business Overview
Table 110. Antibodies Antibody Conjugation Service Product
Table 111. Antibodies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 112. Antibodies Recent Development
Table 113. Boster Biological Technology Company Detail
Table 114. Boster Biological Technology Business Overview
Table 115. Boster Biological Technology Antibody Conjugation Service Product
Table 116. Boster Biological Technology Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 117. Boster Biological Technology Recent Development
Table 118. Cygnus Technologies Company Detail
Table 119. Cygnus Technologies Business Overview
Table 120. Cygnus Technologies Antibody Conjugation Service Product
Table 121. Cygnus Technologies Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 122. Cygnus Technologies Recent Development
Table 123. Cayman Chemical Company Detail
Table 124. Cayman Chemical Business Overview
Table 125. Cayman Chemical Antibody Conjugation Service Product
Table 126. Cayman Chemical Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 127. Cayman Chemical Recent Development
Table 128. GeneTex Company Detail
Table 129. GeneTex Business Overview
Table 130. GeneTex Antibody Conjugation Service Product
Table 131. GeneTex Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 132. GeneTex Recent Development
Table 133. ProteoGenix Company Detail
Table 134. ProteoGenix Business Overview
Table 135. ProteoGenix Antibody Conjugation Service Product
Table 136. ProteoGenix Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 137. ProteoGenix Recent Development
Table 138. Levena Biopharma Company Detail
Table 139. Levena Biopharma Business Overview
Table 140. Levena Biopharma Antibody Conjugation Service Product
Table 141. Levena Biopharma Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 142. Levena Biopharma Recent Development
Table 143. Merck Company Detail
Table 144. Merck Business Overview
Table 145. Merck Antibody Conjugation Service Product
Table 146. Merck Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 147. Merck Recent Development
Table 148. Lonza Company Detail
Table 149. Lonza Business Overview
Table 150. Lonza Antibody Conjugation Service Product
Table 151. Lonza Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 152. Lonza Recent Development
Table 153. Charles River Company Detail
Table 154. Charles River Business Overview
Table 155. Charles River Antibody Conjugation Service Product
Table 156. Charles River Revenue in Antibody Conjugation Service Business (2019-2024) & (US$ Million)
Table 157. Charles River Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Conjugation Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antibody Conjugation Service Market Share by Type: 2023 VS 2030
Figure 3. Chemical Compound Features
Figure 4. Fluorescent Group Features
Figure 5. Isotope Features
Figure 6. Protein Features
Figure 7. Global Antibody Conjugation Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Antibody Conjugation Service Market Share by Application: 2023 VS 2030
Figure 9. Biotechnology Case Studies
Figure 10. Medical Case Studies
Figure 11. University Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Conjugation Service Report Years Considered
Figure 14. Global Antibody Conjugation Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Antibody Conjugation Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Antibody Conjugation Service Market Share by Region: 2023 VS 2030
Figure 17. Global Antibody Conjugation Service Market Share by Players in 2023
Figure 18. Global Top Antibody Conjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Conjugation Service as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Conjugation Service Revenue in 2023
Figure 20. North America Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 22. United States Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 26. Germany Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Antibody Conjugation Service Market Share by Region (2019-2030)
Figure 34. China Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 42. Mexico Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Antibody Conjugation Service Market Share by Country (2019-2030)
Figure 46. Turkey Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Antibody Conjugation Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. ProSci, Inc Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 50. Abcam Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 51. Cell Signaling Technology Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 52. Bio X Cell Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 53. SouthernBiotech Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 54. Novus Biologicals Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 55. GenScript Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 56. Leinco Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 57. Standard BioTools Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 58. AlphaThera Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 59. Creative Biolabs Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 60. Antibodies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 61. Boster Biological Technology Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 62. Cygnus Technologies Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 63. Cayman Chemical Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 64. GeneTex Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 65. ProteoGenix Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 66. Levena Biopharma Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 67. Merck Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 68. Lonza Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 69. Charles River Revenue Growth Rate in Antibody Conjugation Service Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232